FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1142215006: Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4537011019 Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4537012014 Neomycin sulfate 5 mg/mL and prednisolone sodium phosphate 5 mg/mL ear or eye drops en Synonym Active Only initial character case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has manufactured dose form Conventional release ear or eye drops true Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Is a Product containing only neomycin and prednisolone in ocular dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Is a Product containing only neomycin and prednisolone in otic dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has basis of strength substance Neomycin sulfate true Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has concentration strength denominator unit Milliliter true Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has precise active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has basis of strength substance Prednisolone sodium phosphate true Inferred relationship Existential restriction modifier 2
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has concentration strength denominator unit Milliliter true Inferred relationship Existential restriction modifier 2
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has precise active ingredient Prednisolone sodium phosphate true Inferred relationship Existential restriction modifier 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start